Literature DB >> 17913112

Use of calcaneal ultrasound and biochemical markers to assess the density and metabolic state of the bones of adults with hepatic cirrhosis.

Dorothy J VanderJagt1, Edith Okeke, Christine Calvin, Carmen Troncoso, Michael Crossey, Robert H Glew.   

Abstract

Bone loss has been shown to be associated with chronic liver disease (CLD) caused by ethanol consumption or viral infection, and trabecular bone is affected more than cortical bone. We therefore used calcaneal ultrasound to compare the bone status of 54 males and 20 females with CLD in northern Nigeria with 88 age- and gender-matched healthy controls. Serum levels of bone-specific alkaline phosphatase (BSAP) and the N-terminal telopeptide of type-1 collagen (NTx) were also measured to estimate relative rates of bone synthesis and turnover, respectively. The mean stiffness index (SI) of the males with CLD and the male controls were not different; however, the mean SI of the female subjects with CLD was lower than for the female controls (101 vs. 86, p=0.003). The levels of NTx and BSAP were markedly elevated in the males, but not in the females, with CLD. Liver function tests did not correlate with ultrasound parameters or biochemical markers of bone metabolism. These results show that Nigerian women, but not males, with CLD have decreased bone density as assessed by calcaneal ultrasound; however, the high rate of bone turnover in Nigerian males with CLD indicates that they are at risk for bone loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913112      PMCID: PMC2575867     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  26 in total

Review 1.  Improved citation status of World Journal Gastroenterology in 2004: Analysis of all reference citations by WJG and citations of WJG articles by other SCI journals during 1998-2004.

Authors:  Lian-Sheng Ma; Bo-Rong Pan; Wu-Zhou Li; Shi-Yu Guo
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

2.  Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.

Authors:  N Guañabens; A Parés; L Alvarez; M J Martínez de Osaba; A Monegal; P Peris; A M Ballesta; J Rodés
Journal:  J Bone Miner Res       Date:  1998-04       Impact factor: 6.741

3.  Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload.

Authors:  L Sinigaglia; S Fargion; A L Fracanzani; L Binelli; N Battafarano; M Varenna; A Piperno; G Fiorelli
Journal:  J Rheumatol       Date:  1997-09       Impact factor: 4.666

4.  Assessment of the bone status of Nigerian women by ultrasound and biochemical markers.

Authors:  D J Vanderjagt; B Bond; R Dulai; A Pickel; I O Ujah; W W Wadinga; J K Scariano; R H Glew
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

5.  Risk factors for cardiovascular disease and diet of urban and rural dwellers in northern Nigeria.

Authors:  Robert H Glew; Carole A Conn; Thomas A Vanderjagt; Christine D Calvin; Michael O Obadofin; Michael Crossey; Dorothy J Vanderjagt
Journal:  J Health Popul Nutr       Date:  2004-12       Impact factor: 2.000

6.  Increased rate of bone loss at the femoral neck in patients with chronic liver disease.

Authors:  Sif Ormarsdóttir; Osten Ljunggren; Hans Mallmin; Karl Michaëlsson; Lars Lööf
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 2.566

7.  Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

Authors:  F J Gallego-Rojo; J L Gonzalez-Calvin; M Muñoz-Torres; J L Mundi; R Fernandez-Perez; D Rodrigo-Moreno
Journal:  Hepatology       Date:  1998-09       Impact factor: 17.425

8.  Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment.

Authors:  A Cemborain; I Castilla-Cortázar; M García; J Quiroga; B Muguerza; A Picardi; S Santidrián; J Prieto
Journal:  J Hepatol       Date:  1998-01       Impact factor: 25.083

9.  Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis.

Authors:  A Bagur; C Mautalen; J Findor; J Sorda; J Somoza
Journal:  Calcif Tissue Int       Date:  1998-11       Impact factor: 4.333

Review 10.  Cytokines and alcoholic liver disease.

Authors:  C J McClain; S Shedlofsky; S Barve; D B Hill
Journal:  Alcohol Health Res World       Date:  1997
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.